Posts

CMS Plans to Fast‑Track New Health Technologies and AI Tools for Medicare Beneficiaries

on

AstraZeneca CEO says AI is reshaping drug development and helping boost the odds of success

on

Lilly, BMS, Incyte strike deals to keep biopharma’s AI integration rolling

on

Incyte inks deal with Edison Scientific to train AI through drug discovery

on

Novartis CEO Vas Narasimhan Joins Anthropic Board to Advance Responsible AI in Healthcare

on

Novo Nordisk Partners with OpenAI to Accelerate Drug Development

on

AilsynBio and Dong-E-E-Jiao Sign Project Cooperation Agreement Empowering Traditional Medicine with AI

on

Anthropic Acquires Stealth AI Biotech Startup Coefficient Bio in $400M Stock Deal

on

Anumana Secures FDA Clearance for First-of-Its-Kind ECG-AI Algorithm for Early Detection of Pulmonary Hypertension

on

FDA Clears Philips' EchoNavigator R5.0 with DeviceGuide for Real-Time AI Guidance in Minimally Invasive Mitral Valve Repair

on

mAbxience and HP Drive the Use of Artificial Intelligence in Biomanufacturing and Biosimilar Development

on

AI Proteins Raises $41.5M Series A to Accelerate AI-Designed De Novo Miniprotein Therapeutics

on

Lunit and Labcorp Partner to Transform Tumor Microenvironment Analysis with AI-Powered Digital Pathology

on

Candel Therapeutics Showcases Immunotherapy Leadership at SITC 2025, Highlighting Integration of Clinical Innovation, Multi-Omics, and AI for Solid Tumor Therapies

on

Eli Lilly and Nvidia to Build Pharma’s Largest AI Supercomputer for Drug Discovery

on

From JP Morgan to the Next Wave: What’s Driving Biotech in 2026

on

AI is Transforming Drug Safety—But Governance Sets Essential Guardrails

on

Thyme Care Raises $97 Million Series D to Drive AI-Powered Oncology Care at $1B Valuation

on

Eli Lilly Invests $6.5 Billion in Texas Facility to Manufacture Obesity Pill

on

AstraZeneca and SOPHiA GENETICS Expand AI-Powered Cancer Testing Collaboration

on